Nature Portfolio Communications

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Nature Portfolio Communications

Mar 30, 2025, 12:34 | Blog

Ross Upton: External Validation of AI for Detecting Heart Failure with Preserved Ejection Fraction

Ross Upton, Founder, CEO and Chief Scientific Officer at Ultromics , posted on LinkedIn, about…

Jul 4, 2024, 13:56 | Insight

Kelsey Bennion: Another piece to the puzzle of how CD8 T cells make their own off switch along the autocrine signaling axis

Kelsey Bennion, PhD Candidate at Emory University, shared on LinkedIn: "The second first-author publication from…

All: 2 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023